ShareThis Page
Scientists to learn to find bucks for biotech |

Scientists to learn to find bucks for biotech

Luis Fábregas
| Monday, March 17, 2003 12:00 a.m

Scientists gathering in Pittsburgh this week are calling for more federal research money to speed up the creation of man-made human tissues and organs.

One of the key issues at this year’s Engineering Tissue Growth international conference is the need to quickly commercialize bioengineered products such as cartilage to treat arthritis and liver cell implants to stave off liver failure. But bringing those discoveries from the laboratories to the marketplace can’t happen without more money.

“Anything that comes to market has to go through significant human testing and approval, which can mean hundreds of millions of dollars,” said Lisa Kurek, managing partner of Biotechnology Business Consultants in Ann Arbor, Mich., and one of the keynote speakers at the conference. “A lot of scientists are clueless about how to build on the money they have and how to leverage federal resources.”

Leaders of the Pittsburgh Tissue Engineering Initiative, the main sponsor of the four-day event, have rounded up biotech experts to teach some marketing savvy to nearly 600 scientists from around the world. A recurring theme will be how to make the best use of the little money there is to support their work.

“All of this hype and promise won’t come without an investment,” said Alan J. Russell, executive director of the Pittsburgh Tissue Engineering Initiative and director of the McGowan Institute for Regenerative Medicine. “A lot of people are talking about cures for diabetes and Parkinson’s disease and that’s wonderful, but our responsibility is to deliver on that promise.”

To that end, Russell said, scientists in Pittsburgh aren’t just waiting for federal dollars. In fact, the engineering initiative is partnering with scientists from Germany and Japan to find research projects in which the three groups can collaborate.

Russell said Japanese scientists at the Kansai Tissue Engineering Initiative have special expertise in developmental biology and experts at the German Regenerative Medicine Institute have shown strength in the development of an artificial liver.

“I do hope that we can collaborate in some substantive research projects where we can combine our strengths,” Russell said.

He said the Japanese government has invested about $2.4 billion, or $160 million a year, in tissue engineering, compared to about $100 million a year provided to scientists by the U.S. government. The Pittsburgh Tissue Engineering Initiative believes that number should be bumped up to about $800 million a year, with special attention to areas that are lacking support, such as basic and applied research and money for clinical trials.

The Engineering Tissue Growth Conference, now in its third year, runs through Thursday at the Westin Convention Center Hotel, Downtown.

Categories: News
TribLIVE commenting policy

You are solely responsible for your comments and by using you agree to our Terms of Service.

We moderate comments. Our goal is to provide substantive commentary for a general readership. By screening submissions, we provide a space where readers can share intelligent and informed commentary that enhances the quality of our news and information.

While most comments will be posted if they are on-topic and not abusive, moderating decisions are subjective. We will make them as carefully and consistently as we can. Because of the volume of reader comments, we cannot review individual moderation decisions with readers.

We value thoughtful comments representing a range of views that make their point quickly and politely. We make an effort to protect discussions from repeated comments either by the same reader or different readers

We follow the same standards for taste as the daily newspaper. A few things we won't tolerate: personal attacks, obscenity, vulgarity, profanity (including expletives and letters followed by dashes), commercial promotion, impersonations, incoherence, proselytizing and SHOUTING. Don't include URLs to Web sites.

We do not edit comments. They are either approved or deleted. We reserve the right to edit a comment that is quoted or excerpted in an article. In this case, we may fix spelling and punctuation.

We welcome strong opinions and criticism of our work, but we don't want comments to become bogged down with discussions of our policies and we will moderate accordingly.

We appreciate it when readers and people quoted in articles or blog posts point out errors of fact or emphasis and will investigate all assertions. But these suggestions should be sent via e-mail. To avoid distracting other readers, we won't publish comments that suggest a correction. Instead, corrections will be made in a blog post or in an article.